Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer
Y.Q. Li, Y. Li, S. Wedren, G.L. Li, T.H. Charn, K.V. Desai, C. Bonnard, K. Czene, K. Humphreys, H. Darabi, Kristjana Einarsdottir, T. Heikkinen, K. Aittomaki, C. Blomqvist, K.S. Chia, H. Nevanlinna, P. Hall, E.T. Liu, J.J. Liu
Research output: Contribution to journal › Article › peer-review
22Citations
(Web of Science)
Fingerprint
Dive into the research topics of 'Genetic variation of ESR1 and its co-activator PPARGC1B is synergistic in augmenting the risk of estrogen receptor-positive breast cancer'. Together they form a unique fingerprint.